Samsung Research Reveals Over Half of Europeans Admit to Looking at a Stranger’s Phone Screen in Public – With Nearly a Quarter Doing so out of Sheer Curiosity
From dating apps to financial details, respondents report seeing a wide range of highly personal information on others’ screens 56% of people admit to having... Read more.
Airwallex Secures Key Regulatory Approvals for Full Commercial Launch in Malaysia
Airwallex obtains e-money and Class A licences from Bank Negara Malaysia, unlocking full local operations With this expanded offering, Airwallex distinguishes itself... Read more.
RevolKa Reimagines Antibody Engineering with “RevoAb®”
A Same-day Sequence Optimization Service to Elevate Antibody Expression Levels by RevolKa’s advanced AI Protein Engineering Engine SENDAI, Japan–(BUSINESS... Read more.
Versigent Launches as New Publicly Traded Company
Company Positioned for Success and Value Creation as Leading Global Provider of Signal, Data & Power Distribution Systems Versigent to Begin Trading on the New... Read more.
No one listened. Then a Dante Labs Whole Genome Report Gave a Single Mother’s Two Children a Name for Their Disease and Access to the Specialists They Needed
NEW YORK–(BUSINESS WIRE)–#dante–For years, Susan watched her two children collapse without warning. Episodes of sudden, full-body muscle weakness... Read more.
Mitsubishi Electric Group Launches New Corporate Philosophy
Promoting transformation into an “Innovative Company” TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it... Read more.
Kontrol Technologies Announces Fourth Quarter and Fiscal Year 2025 Financial Results
TORONTO–(BUSINESS WIRE)–$KNR #esg—Kontrol Technologies Corp. (CBOE.CA:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol Technologies” or “Kontrol”... Read more.
Kontrol Technologies Announces Fourth Quarter and Fiscal Year 2025 Financial Results
TORONTO–(BUSINESS WIRE)–$KNR #esg—Kontrol Technologies Corp. (CBOE.CA:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol Technologies” or “Kontrol”... Read more.
Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc – CNTA
NEW YORK CITY & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick &... Read more.
Apellis Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apellis Pharmaceuticals, Inc. – APLS
NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti,... Read more.